Medicarta AB is a Swedish AB based in Uddevalla, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1995, the company has 0 employees.
Solidity ratio Equity ÷ Total assets × 100 Among the 20% highest rated companies in the industry
2021 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 30% highest rated companies in the industry
2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 30% lowest rated companies in the industry
2021 2025
EBITDA — year on year SEK thousands 0 -12 -25 -37 -50 2021: -16 -16 2021 2022: -24 (-50% vs 2021) -24 -50% 2022 2023: -24 (0% vs 2022) -24 0% 2023 2024: -40 (-67% vs 2023) -40 -67% 2024 2025: -18 (+55% vs 2024) -18 +55% 2025
Key figures Annual report 2025 Gross profit — — EBITDA -0M SEK +54% Net profit -0M SEK -101% Total assets 4.3M SEK -5% Equity 4.1M SEK -5% Employees 0 —
Founded
24 July 1995 · 31 years
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Nilsson, Pär Michael
Company purpose
Bolaget skall bedriva medicinsk konsultation samt kapital- förvaltning ävensom idka därmed förenlig verksamhet.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 6.7k.
At the end of 2025, equity financed 94.8% of the balance sheet, and current assets covered short-term debt 7.4 times.
Frequently asked questions What is the Org number of Medicarta AB? Medicarta AB is registered with Bolagsverket / SCB under Org 5565226213.
Who is the chairman of Medicarta AB? Pär Michael Nilsson chairs the board of Medicarta AB, in role since 2022.
Where is Medicarta AB headquartered? Medicarta AB's registered address is Kristinebergsvägen 22.
